USPTO Memo Cuts Mayo Woes On Treatment Method Patents

New guidance from the U.S. Patent and Trademark Office suggests that patents on methods of treating disease should usually be considered patent-eligible, freeing patent holders from having to grapple with the...

Already a subscriber? Click here to view full article